As per the GOI circular on price capping of Orthopaedic Knee implant by NPPA(National Pharmaceutical Pricing Authority), new prices of knee implants have been implemented effective 16th August 2017. For details on knee implant pricing across our hospitals. CLICK HERE | As per GOI’s circular dated 02nd April 2018 on price-capping of stents by NPPA(National Pharmaceutical Pricing Authority), new prices of coronary stents are revised with effect from 01st April, 2018. For details on stent pricing.CLICK HERE
Doctor Profile
Dr. Bhawana Saddy Awasthy

Dr. Bhawana Saddy Awasthy,

MBBS DNB

Senior consultant, Fortis Hospital Vasant Kunj

Medical Oncology

OPD Schedule - +91 11 4277 6222

  • Mon

    12:00 PM - 03:00 PM

  • Tue

    12:00 PM - 03:00 PM

  • Wed

    12:00 PM - 03:00 PM

  • Thu

    12:00 PM - 03:00 PM

  • Fri

    12:00 PM - 03:00 PM

  • Sat

    12:00 PM - 03:00 PM

  •  
    Book an Appointment
     
    Pay Online and Get 10% Off

Dr. Awasthy is a clinical oncologist with 20 years of combined clinical-practice and clinical-research experience. She has been involved in medical treatment and radiation therapy of solid tumors, and lymphomas. After 12 years at the All India Institute of Medical Sciences, New Delhi, she moved into the private sector, and has been practicing oncology in major private hospitals in Delhi. Her research responsibilities have included developing, designing and conducting oncology clinical trials, for the pharmaceutical industry and for academic institutions. She has published in peer reviewed journals, and has made multiple presentations at national and international oncology conferences.She has held leadership positions in the industry, organizing and managing both oncology research and global drug development. Among other things, this has included the planning of oncology biomarker research capabilities for a network of oncology hospitals in India. Her responsibilities have included oncologist group engagement activities at an international level, development of research committees and ethics committee systems and processes, following the requirements of the US FDA in an Indian setting.